Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics

Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics

OBJECTIVE: To compare the activity of piperacillin/tazobactam with that of other broad parenteral antibiotics against aerobic and facultative anaerobic blood culture isolates in a Canada-wide survey.

Saved in:

Bibliographic Details
Main Authors:	Kevin R Forward, Patricia A Franks, Donald E Low, Robert Rennie, Andrew E Simor, the Canadian Piperacillin/Tazobactam Study Group
Format:	Article
Language:	English
Published:	Wiley 1998-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1998/730838
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates
by: Kevin R Forward, et al.
Published: (1997-01-01)

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa
by: Vladimir Chachanidze, et al.
Published: (2009-01-01)

Acute Kidney Injury in Pediatric Treated with Vancomycin and Piperacillin-Tazobactam in Tertiary Care Hospital
by: Mohammed Al Nuhait, et al.
Published: (2018-01-01)

Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia
by: Laila M. Najia, et al.
Published: (2023-01-01)

Interdisciplinary Team Pilot to Reduce Time to Administration of Piperacillin/Tazobactam in the Emergency Department at a Veterans Affairs Medical Center
by: DiVittorio MM, et al.
Published: (2025-02-01)

Comparative Activity of Several Antimicrobial Agents against Nosocomial Gram-Negative Rods Isolated across Canada
by: Shelley R Scriver, et al.
Published: (1995-01-01)

A Case of Bacteremia and Meningitis Associated with Piperacillin-Tazobactam Nonsusceptible, Ceftriaxone Susceptible Escherichia coli during Strongyloides Hyperinfection in an Immunocompromised Host
by: Santosh Dahal, et al.
Published: (2017-01-01)

Community-Acquired Antibiotic Resistance in Urinary Isolates from Adult Women in Canada
by: Warren J McIsaac, et al.
Published: (2006-01-01)

Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
by: Louie Mar Gangcuangco, et al.
Published: (2016-01-01)

The Evolution of Antimicrobial Resistance in Respiratory Pathogens in Canada: What are the Clinical Consequences?
by: Donald E Low
Published: (1998-01-01)

Antibiotic resistance in Canada and the Canadian Committee on Antibiotic Resistance
by: John Conly
Published: (2000-01-01)

Assuring Quality in Canada’s Microbiology Laboratories
by: Kevin R Forward
Published: (1996-01-01)

A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP)
by: Junjie Li, et al.
Published: (2025-04-01)

In Vitro Activity of Cefepime against Multidrug-Resistant Gram-Negative Bacilli, Viridans Group Streptococci and Streptococcus pneumoniae from a Cross-Canada Surveillance Study
by: Donald E Low, et al.
Published: (1999-01-01)

Piperacillin-Induced Immune Hemolytic Anemia in an Adult with Cystic Fibrosis
by: Mahesh Bandara, et al.
Published: (2010-01-01)

Piperacillin-Associated Pulmonary Infiltrates with Eosinophilia: A Case Report
by: Olivia Ling-I Tseng, et al.
Published: (2010-01-01)

Torsade de Pointes Induced by Hypokalemia from Imipenem and Piperacillin
by: Varun Kumar, et al.
Published: (2017-01-01)

Piperacillin-Induced Immune Hemolysis Presenting with Tachycardia and Cardiac Arrest
by: Ghan-Shyam Lohiya, et al.
Published: (2011-01-01)

The Threat of the Emergence of Antimicrobial-Resistant Gram-Positive Pathogens in Canada
by: Donald E Low, et al.
Published: (1994-01-01)

Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
by: Warren J McIsaac, et al.
Published: (2013-01-01)

RP-HPLC Method for Simultaneous Estimation of Cefepime Hydrochloride and Tazobactam Sodium in Bulk and Pharmaceuticals
by: Sagar R. Tamboli, et al.
Published: (2013-01-01)

Transfusion and Risk of Infection in Canada
by: Canadian Paediatric Society, Infectious Diseases and Immunization Committee
Published: (2003-01-01)

Antimicrobial Resistance in Canada: Update on Activities of the Canadian Committee on Antibiotic Resistance
by: John Conly
Published: (2002-01-01)

Antimicrobial Resistance in Canada: An Update on Activities of the Canadian Committee on Antibiotic Resistance
by: John Conly
Published: (2001-01-01)

Transfusion and Risk of Infection in Canada: UPDATE 2004
by: Canadian Paediatric Society, Infectious Diseases and Immunization Committee
Published: (2004-01-01)

Antibiotic Resistance in Canada at the Dawn of the New Millennium -- A Model for the Developed World?
by: John M Conly, et al.
Published: (2000-01-01)

Research Funding for Pain in Canada
by: Mary E Lynch, et al.
Published: (2009-01-01)

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
by: Erik Skoglund, et al.
Published: (2018-01-01)

Antimicrobial Resistance: An Update from the Canadian Committee on Antibiotic Resistance
by: Canadian Committee on Antibiotic Resistance
Published: (2005-01-01)

Influence of 16S Ribosomal RNA Gene Polymerase Chain Reaction and Sequencing on Antibiotic Management of Bone and Joint Infections
by: B Alraddadi, et al.
Published: (2013-01-01)

Respiratory Guidelines Implementation in Canada
by: Louis-Philippe Boulet, et al.
Published: (2007-01-01)

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”
by: Erik Skoglund, et al.
Published: (2019-01-01)

Antibiotic resistance among Aerobic Gram-Negative Bacilli isolated from patients with oral inflammatory dysbiotic conditions—a retrospective study
by: A. Basic, et al.
Published: (2024-03-01)

Asthma Education and Management Programs in Canada
by: Robert L Cowie, et al.
Published: (2001-01-01)

The Use of Antibiotic Therapy as an Adjunct in Treatment of Bone and Joint Infections
by: Canadian Paediatric Society, Infectious Diseases and Immunization Committee
Published: (1994-01-01)

Serological Evidence of Increased Coccidioides immitis Infections in Western Canada in 1996
by: Errol Prasad, et al.
Published: (1998-01-01)

The Prevalence of Chronic Pain in Canada
by: Donald Schopflocher, et al.
Published: (2011-01-01)

Pseudomonas Aeruginosa and Cystic Fibrosis: Antibiotic Therapy and the Science behind the Magic
by: Noni E MacDonald
Published: (1997-01-01)

Canadian Helicobacter pylori Consensus Conference Update: Infections in Adults
by: RH Hunt, et al.
Published: (1999-01-01)

Immunomodulatory Effects of Aerobic Training in Obesity
by: Thomas Nickel, et al.
Published: (2011-01-01)